AMERICAN SOCIETY OF CLINICAL ONCOLOGY: Form 990, tax year 2023
View the entire original 990 at ProPublica ↗
- Organization
- AMERICAN SOCIETY OF CLINICAL ONCOLOGY (EIN 13-6180380)
- Tax period
- 2023-01-01 to 2023-12-31
- Filed
- 2024-11-15
- IRS object ID
- 202423209349300917
- Schema version
- 2023v5.1
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule I
- Schedule J
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2024-11-15T01:30:40-06:00 | ReturnTs |
| Tax Period End | 2023-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 221478099 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | COHNREZNICK LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 7501 WISCONSIN AVENUE SUITE 400E | AddressLine1Txt |
| City | BETHESDA | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 20814 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2023-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 136180380 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | AMERICAN SOCIETY OF CLINICAL ONCOLOGY | BusinessNameLine1Txt |
| Business Name Line2 | INC | BusinessNameLine2Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | AMER | BusinessNameControlTxt |
| Phone | 5714831300 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2318 MILL ROAD 800 | AddressLine1Txt |
| City | ALEXANDRIA | CityNm |
| State Abbreviation | VA | StateAbbreviationCd |
| ZIP | 22314 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | MELINDA O'LEARY | PersonNm |
| Person Title | CFO | PersonTitleTxt |
| Phone | 5714831300 | PhoneNum |
| Signature | 2024-11-14 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| IRS Responsible Prty Info Curr | Yes (1) | IRSResponsiblePrtyInfoCurrInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | LORI ROTHE YOKOBOSKY CPA | PreparerPersonNm |
| PTIN | P01273422 | PTIN |
| Phone | 3016529100 | PhoneNum |
| Preparation | 2024-11-13 | PreparationDt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2023 | TaxYr |
| Build TS | 2024-10-15 13:58:12Z | BuildTS |
Form 990 IRS990
Doing Business As Name DoingBusinessAsName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ASCO | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | CLIFFORD HUDIS MD CEO | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2318 MILL ROAD 800 | AddressLine1Txt |
| City | ALEXANDRIA | CityNm |
| State Abbreviation | VA | StateAbbreviationCd |
| ZIP | 22314 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $202,755,721 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.ASCO.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1965 | FormationYr |
| Legal Domicile State | NY | LegalDomicileStateCd |
| Activity Or Mission | SEE SCHEDULE O:ASCO IS A PROFESSIONAL ONCOLOGY SOCIETY COMMITTED TO CONQUERING CANCER THROUGH RESEARCH, EDUCATION, AND PROMOTION OF THE HIGHEST QUALITY, EQUITABLE PATIENT CARE. | ActivityOrMissionDesc |
| Voting Members Governing Body | 18 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 18 | VotingMembersIndependentCnt |
| Total Employee | 520 | TotalEmployeeCnt |
| Total Volunteers | 4125 | TotalVolunteersCnt |
| Total Gross UBI | $13,695,298 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $6,952,857 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $9,250,760 | PYContributionsGrantsAmt |
| CY Contributions Grants | $16,259,283 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $123,943,513 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $127,986,242 | CYProgramServiceRevenueAmt |
| PY Investment Income | $2,024,051 | PYInvestmentIncomeAmt |
| CY Investment Income | $23,661,513 | CYInvestmentIncomeAmt |
| PY Other Revenue | $10,921,536 | PYOtherRevenueAmt |
| CY Other Revenue | $6,430,255 | CYOtherRevenueAmt |
| PY Total Revenue | $146,139,860 | PYTotalRevenueAmt |
| CY Total Revenue | $174,337,293 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $4,042,358 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $4,632,496 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $64,467,166 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $70,278,616 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $0 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $75,760,362 | PYOtherExpensesAmt |
| CY Other Expenses | $80,576,931 | CYOtherExpensesAmt |
| PY Total Expenses | $144,269,886 | PYTotalExpensesAmt |
| CY Total Expenses | $155,488,043 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $1,869,974 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $18,849,250 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $251,452,025 | TotalAssetsBOYAmt |
| Total Assets EOY | $296,538,439 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $107,117,119 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $112,691,951 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $144,334,906 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $183,846,488 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | SEE SCHEDULE O: | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $64,315,059 | ExpenseAmt |
| Grant | $440,180 | GrantAmt |
| Revenue | $99,649,143 | RevenueAmt |
| Desc | SEE SCHEDULE O:SCIENTIFIC & MEDICAL EDUCATION:ASCO'S MEETING PORTFOLIO DELIVERS TO ASCO'S CORE AUDIENCE OF HEALTH PROFESSIONALS, THE SCIENCE AND EDUCATION CRITICAL TO IMPROVING PATIENT CARE AND CLINICAL PRACTICE BY HOSTING CONFERENCES THAT BRING TOGETHER FACULTY AND PRACTITIONERS BOTH IN-PERSON AND ONLINE. IN 2023, ASCO'S PREMIER ANNUAL MEETING, THROUGH OVER 220 SESSIONS, REACHED AN AUDIENCE OF 36,750 PROFESSIONALS, INCLUDING OVER 14,000 PROFESSIONALS FROM 140 NON-US COUNTRIES, BOTH IN-PERSON AND ONLINE. THROUGH ASCO'S ADDITIONAL MEETINGS, THE ASCO GASTROINTESTINAL CANCERS SYMPOSIUM, THE ASCO GENITOURINARY CANCERS SYMPOSIUM, THE ASCO QUALITY CARE SYMPOSIUM, ASCO BREAKTHROUGH, AND THE BEST OF ASCO ANNUAL MEETING, A FURTHER 11,325 PROFESSIONALS, OVER 4,600 OF WHOM WERE OUTSIDE THE UNITED STATES, BENEFITED FROM THE EDUCATION, SCIENCE, AND NETWORKING THAT ASCO PROVIDED. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $22,720,123 | ExpenseAmt |
| Grant | $5,000 | GrantAmt |
| Revenue | $6,060,926 | RevenueAmt |
| Desc | SEE SCHEDULE O:QUALITY OF CARE INITIATIVES - CANCERLINQ, QUALITY MEASURES, GUIDELINES AND QOPI:QUALITY ONCOLOGY PRACTICE INITIATIVE (QOPI). A QUALITY SELF ASSESSMENT AND IMPROVEMENT PROGRAM FOR OUTPATIENT MEDICAL ONCOLOGY AND HEMATOLOGY-ONCOLOGY PRACTICES: QOPI PROVIDES A WEB-BASED DATA COLLECTION TOOL THAT ALLOWS PRACTICES TO 1) REPORT ON VARIOUS CANCER CARE QUALITY MEASURES, 2) RECEIVE ANALYZED DATA ON PRACTICE PERFORMANCE, AND 3) COMPARE PERFORMANCE AGAINST THEIR PEERS FOR DATA-DRIVEN IMPROVEMENT ACTIVITIES. PRACTICES PARTICIPATE ANNUALLY AND OVER 263 PRATICES PARTICAPTED IN 2023.QUALITY TRAINING PROGRAM. ASCO'S QUALITY TRAINING PROGRAM IS DESIGNED TO EDUCATE AND TRAIN HEMATOLGY-ONOCOLOGY PRACTICE TEAMS, THE TECHNIQUES OF CLINICAL CARE AND OPERATIONAL PERFORMANCE QUALITY IMPROVEMENT. RECENT PARTICPANTS HAVE INCLUDED, BY INTENTIONAL RECRUITMENT, PRACTICES SERVING URBAN AND RURAL UNDERSERVED POPULATIONS ADRESSING HEALTH DISPARITY. 290 ONCOLOGY PROFESSIONALS RECEIVED TRAINING IN 2023.GUIDELINES:A CRITICAL COMPONENT OF THE SOCIETY'S QUALITY EFFORTS, THE ASCO GUIDELINES PROGRAM ACTIVELY ENGAGES WITH MORE THAN 1,000 ASCO MEMBER VOLUNTEERS, ON A YEARLY BASIS, TO DEVELOP EVIDENCE AND EXPERT-DRIVEN RECOMMENDATIONS THAT INFORM HIGH-QUALITY AND EQUITABLE CANCER CARE WORLDWIDE. ASCO'S GUIDELINES PROGRAM WHICH INCLUDES TRADITIONAL AS WELL AS LIVING CLINICAL PRACTICE GUIDELINES, UPDATES, AND ORGANIZATIONAL STANDARDS, FOCUSES ON CONTENT AREAS WITH IDENTIFIED KNOWLEDGE GAPS, HIGH UNCERTAINTY, OR UNMET AND PRESSING CLINICAL NEEDS FACING ONCOLOGY CARE TEAMS IN CLINICAL PRACTICE. ASCO'S GUIDELINES RESOURCES ARE DESIGNED TO PROMOTE GUIDELINE-CONCORDANT CANCER CARE AT THE CLINICIAN, CAREGIVER, AND PATIENT LEVEL. FOR PATIENTS AND CAREGIVERS, COMPLEX GUIDELINE INFORMATION IS DISTILLED AND PRESENTED IN A USER-FRIENDLY FORMAT THROUGH ASCO'S CANCER.NET. FOR CLINICIANS, THESE TOOLS ARE OFFERED THROUGH CONCISE PRACTICE-FACING COMPANION ARTICLES, SUMMARY RECOMMENDATION TABLES, ALGORITHMS, PODCASTS, VISUAL ABSTRACTS, AND OTHER RESOURCES THAT ARE ACCESSIBLE THROUGH ASCO JOURNALS, THE ASCO WEBSITE, AND THE ASCO GUIDELINES APP.PUBLISHED AS A REGULAR, AND OFTEN MOST READ, FEATURE IN THE JOURNAL OF CLINICAL ONCOLOGY (JCO) WITH OVER 1.3 MILLION DOWNLOADS IN 2023, GUIDELINES ALSO SERVE AS THE EVIDENCE FOUNDATION FOR ASCO'S MEMBER EDUCATION, PATIENT EDUCATION, POLICY, CARE DELIVERY, AND QUALITY EFFORTS, ALL WITH THE GOAL OF CANCER TREATMENT AND CARE INFORMED BY THE HIGHEST QUALITY EVIDENCE AND EXPERT INTERPRETATION, INTEGRATED INTO GLOBAL PRACTICE AT THE POINT OF PATIENT CARE. ASCO TYPICALLY ENGAGES 30-40 GUIDELINE EXPERT PANELS AT ANY GIVEN TIME AND PUBLISHES BETWEEN 20-25 NEW OR UPDATED GUIDELINES EACH YEAR; WITH A GROWING LIBRARY OF GUIDELINE SUMMARIES THAT HAVE BEEN TRANSLATED INTO SPANISH. TWENTY-THREE GUIDELINE PRODUCTS WERE PUBLISHED IN THE JCO IN 2023, INCLUDING SEVERAL RAPID UPDATES AND MULTIPLE ITERATIONS OF ASCO'S COMPREHENSIVE LIVING GUIDELINE ADDRESSING THE CARE OF PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER. IN ADDITION, 13 COMPANION ARTICLES PROVIDING GUIDELINE CLINICAL INSIGHTS WERE PUBLISHED IN THE JCO ONCOLOGY PRACTICE. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $9,157,287 | ExpenseAmt |
| Revenue | $4,332,922 | RevenueAmt |
| Desc | SEE SCHEDULE O:RESEARCH INITIATIVES - TAPUR/CENTRA:ASCO'S CENTER FOR RESEARCH AND ANALYTICS LEADS ASCO'S RESEARCH EFFORTS, INCLUDING ITS CLINICAL CANCER RESEARCH PROGRAMS. MAJOR PROGRAMS AND PROJECTS INCLUDE: (1) THE TARGETED AGENT AND PROFILING UTILIZATION REGISTRY WHICH IS PRECISION MEDICINE BASKET TRIAL INVESTIGATING THE EFFICACY OF MORE THAN 15 DIFFERENT ANTI-CANCER TARGETED AGENTS IN PATIENTS WITH ADVANCED CANCERS AND HAS ENROLLED ALMOST THAN 3,000 PATIENTS SINCE IT OPENED IN 2016 AND CONTINUES TO PUBLISH TRIAL RESULTS IN PEER-REVIEWED CLINICAL CANCER RESEARCH JOURNALS AND PRESENT RESULTS AT CLINICAL CANCER RESEARCH CONFERENCES; (2) ASCO'S COVID-19 REGISTRY WHICH INCLUDES A DATABASE OF OVER 6,000 PATIENTS WITH CANCER AND COVID-19 FROM 2020 TO 2022 AND RESEARCH ON THE DATABASE BY CENTRA STAFF AND MADE AVAILABLE TO EXTERNAL RESEARCHERS (THE REGISTRY CLOSED TO DATA COLLECTION AT THE END OF 2023 ALTHOUGH DATA IS STILL AVAILABLE FOR USE); (3) ASCO'S MEMBER RESEARCH SURVEY POOL, WHICH FACILITATES RESEARCH OF CANCER CARE PROVIDERS BY DISSEMINATING SURVEYS FROM MERITORIOUS SURVEY RESEARCH PROJECTS TO ASCO MEMBERS WHO HAVE AGREED TO BE A PART OF THE SURVEY POOL; (4) THE STATE OF CANCER CARE IN AMERICA PROGRAM, WHICH ASSESSES AND REPORTS ON AND REPORT ON THE STATE OF AND CHANGES IN CANCER CARE IN THE US; (5) ASCO'S WORK IN IMPROVING ACCESS TO CLINICAL TRIALS THROUGH TRAINING FOR SITES AND WORKING TO COMBAT BARRIERS TO ENROLLMENT FOR UNDER-REPRESENTED POPULATIONS OF PATIENTS; AND (6) THE START-UP FOR A NEW CLINICAL RESEARCH STUDY, THE CDK4/6 INHIBITOR DOSING STUDY, WHICH WILL OPEN TO ENROLLMENT IN 2024 AND EVALUATES STANDARD VS. TITRATED DOSING APPROACHES FOR PATIENTS AGE 65 AND OLDER WITH HR+/HER2- METASTATIC BREAST CANCER. CENTRA ALSO SUPPORTS WORKSHOPS, MEETINGS, AND RESEARCH PROJECTS WITH OTHER STAKEHOLDERS IN CANCER RESEARCH, INCLUDING THE NCI, THE FDA'S ONCOLOGY CENTER FOR EXCELLENCE, AND OTHER NON-PROFIT GROUPS, SUCH AS THE FRIENDS OF CANCER RESEARCH. | Desc |
Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $28,526,865 | ExpenseAmt |
| Grant | $4,187,316 | GrantAmt |
| Revenue | $17,943,251 | RevenueAmt |
| Desc | EXAMPLES OF OTHER PROGRAMS:SCIENTIFIC PUBLICATIONS: ASCO PRODUCES A NUMBER OF PROFESSIONAL PUBLICATIONS AND GENERAL PUBLICATIONS FOCUSED ON CLINICAL ONCOLOGY. ASCO PUBLISHES HIGH-QUALITY, PEER-REVIEWED SCIENTIFIC PAPERS IN ITS JOURNALS: - JOURNAL OF CLINICAL ONCOLOGY (JCO)- JCO GLOBAL ONCOLOGY (JCO GO)- JCO CLINICAL CANCER INFORMATICS (JCO CCI)- JCO PRECISION ONCOLOGY (JCO PO)- JCO ONCOLOGY PRACTICE (JCO OP)- ASCO DAILY NEWSASCO ALSO PROVIDES CONTENT AND DISTRIBUTION LISTS FOR TRADE PUBLICATIONS. WHILE NOT OWNED OR PUBLISHED BY ASCO, THE PUBLICATIONS COVER NEWS AND INFORMATION OF INTEREST TO THE PROFESSIONAL ONCOLOGY COMMUNITY.CENTER FOR GLOBAL IMPACT:ASCO'S INTERNATIONAL AFFAIRS DEPARTMENT HAS TRANSITIONED TO THE CENTER FOR GLOBAL IMPACT (CGI). CGI PARTNERS ACROSS ASCO AND ONCOLOGY COMMUNITIES WORLDWIDE TO INTEGRATE GLOBAL PERSPECTIVES INTO ASCO STRATEGIES AND OPERATIONS, AND TO CATALYZE AND ADVANCE ASCO'S GLOBAL IMPACT GOALS AS DIRECTED BY THE SOCIETY'S MISSION, VISION, AND STRATEGIC PLANS. CGI SERVES AS A RESOURCE ACROSS ASCO FOR GLOBAL ISSUES RELEVANT TO ASCO, WITH A PARTICULAR EMPHASIS ON VOLUNTEER ENGAGEMENT, DIPLOMACY, STRATEGIC PLANNING, PROGRAM DELIVERY, AND GLOBAL OPERATIONS. IT DOES THIS THROUGH THE FOLLOWING:JOINT SESSIONS (INTERNATIONAL CANCER CONFERENCES)THE INTERNATIONAL CANCER CORPS' (ICC)THE INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD (IDEA) | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Prog Srvc Expense | $28,526,865 | TotalOtherProgSrvcExpenseAmt |
| Total Other Prog Srvc Grant | $4,187,316 | TotalOtherProgSrvcGrantAmt |
| Total Other Prog Srvc Revenue | $17,943,251 | TotalOtherProgSrvcRevenueAmt |
| Total Program Service Expenses | $124,719,334 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (1) | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | 0 | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (1) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (1) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (1) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | 0 | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (1) | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | Yes (1) | ForeignOfficeInd |
| Foreign Activities | Yes (1) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (1) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | 0 | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Grants To Individuals | 0 | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | 0 | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | 0 | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | Yes (1) | DisregardedEntityInd |
| Related Entity | Yes (1) | RelatedEntityInd |
| Related Organization Ctrl Ent | Yes (1) | RelatedOrganizationCtrlEntInd |
| Transaction With Control Ent | Yes (1) | TransactionWithControlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | Yes (1) | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 629 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (1) | BackupWthldComplianceInd |
| Employee | 520 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (1) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | Yes (1) | UnrelatedBusIncmOverLimitInd |
| Form990 T Filed | Yes (1) | Form990TFiledInd |
| Foreign Financial Account | 0 | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | Yes (1) | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | 0 | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 18 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 18 | IndependentVotingMemberCnt |
| Family Or Business Rln | 0 | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | Yes (1) | MembersOrStockholdersInd |
| Election Of Board Members | Yes (1) | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | Yes (1) | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (1) | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (1) | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VA | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | MELINDA O'LEARY CFO | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 5714831300 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2318 MILL ROAD SUITE 800 | AddressLine1Txt |
| City | ALEXANDRIA | CityNm |
| State Abbreviation | VA | StateAbbreviationCd |
| ZIP | 22314 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (39 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd | Former Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd |
|---|---|---|---|---|---|---|---|---|---|---|
| EVERETT E VOKES MD | ||||||||||
| CHAIR/PAST PRESIDENT | 1.00 | 1.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |||
| ERIC P WINER MD | ||||||||||
| PRESIDENT/CHAIR | 1.00 | 1.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |||
| LYNN M SCHUCHTER MD | ||||||||||
| PRESIDENT-ELECT/PRESIDENT | 1.00 | 2.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |||
| ROBIN ZON MD | ||||||||||
| PRESIDENT-ELECT | 1.00 | 1.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |||
| LORI J PIERCE MD | ||||||||||
| PAST PRESIDENT (PARTIAL YEAR) | 1.00 | 1.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |||
| ELIZABETH A MITTENDORF MD PHD MHC | ||||||||||
| TREASURER (PARTIAL YEAR) | 1.00 | 1.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |||
| ELIZABETH R PLIMACK MD MS | ||||||||||
| TREASURER-ELECT/TREASURER | 1.00 | 1.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |||
| TAOFEEK K OWONIKOKO MD PHD | ||||||||||
| TREASURER-ELECT | 1.00 | 1.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |||
| FREDRICK CHITE ASIRWA MD MBCHB | ||||||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | |||||
| ETHAN M BASCH MD MSC | ||||||||||
| BOARD MEMBER (PARTIAL YEAR) | 1.00 | 1.00 | Yes (X) | $0 | $0 | $0 | ||||
| LISA A CAREY MD | ||||||||||
| BOARD MEMBER | 1.00 | 1.00 | Yes (X) | $0 | $0 | $0 | ||||
| MARIANA CHAVEZ MACGREGOR MD MSC | ||||||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | |||||
| TARA O HENDERSON MD MPH | ||||||||||
| BOARD MEMBER | 1.00 | 1.00 | Yes (X) | $0 | $0 | $0 | ||||
| CAROLYN B HENDRICKS MD | ||||||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | |||||
| KATHLEEN N MOORE MD MS | ||||||||||
| BOARD MEMBER (PARTIAL YEAR) | 1.00 | Yes (X) | $0 | $0 | $0 | |||||
| ANN H PARTRIDGE MD MPH | ||||||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | |||||
| DEBRA PATT MD PHD | ||||||||||
| BOARD MEMBER (PARTIAL YEAR) | 1.00 | Yes (X) | $0 | $0 | $0 | |||||
| ENRIQUE SOTO PEREZ DE CELIS MD MSC | ||||||||||
| BOARD MEMBER | 1.00 | 1.00 | Yes (X) | $0 | $0 | $0 | ||||
| GLADYS I RODRIGUEZ MD | ||||||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | |||||
| JENNIFER TEMEL MD | ||||||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | |||||
| MICHAEL A THOMPSON MD PHD | ||||||||||
| BOARD MEMBER (PARTIAL YEAR) | 1.00 | Yes (X) | $0 | $0 | $0 | |||||
| KAREN M WINKFIELD MD PHD | ||||||||||
| BOARD MEMBER | 1.00 | Yes (X) | $0 | $0 | $0 | |||||
| CLIFFORD A HUDIS MD | ||||||||||
| CEO | 30.00 | 7.50 | Yes (X) | $1,060,801 | $0 | $24,750 | ||||
| DINA MICHELS ESQ | ||||||||||
| SECRETARY, EVP & COO | 37.50 | Yes (X) | $685,749 | $0 | $42,792 | |||||
| LINDA JENSEN | ||||||||||
| EVP & CFO | 30.00 | 7.50 | Yes (X) | $477,532 | $0 | $42,792 | ||||
| JULIE R GRALOW MD | ||||||||||
| EVP & CMO | 37.50 | $632,400 | $0 | $42,792 | Yes (X) | |||||
| NANCY DALY MS MPH | ||||||||||
| EVP & CONQUER CANCER CEO | 1.00 | 36.50 | $516,637 | $0 | $42,677 | Yes (X) | ||||
| CARMEN JACKSON | ||||||||||
| CEO - CLQ | 37.50 | $515,125 | $0 | $49,419 | Yes (X) | |||||
| CHRISTOPHER MERLAN | ||||||||||
| EVP & CHIEF DIGITAL OFFICE | 37.50 | $475,728 | $0 | $44,731 | Yes (X) | |||||
| JAMIE VON ROENN MD MED | ||||||||||
| VP, EDU., SCIENCE & PROF. | 37.50 | $457,512 | $0 | $33,834 | Yes (X) | |||||
| AMANDA DAVIS-AITKEN | ||||||||||
| VICE PRESIDENT, MEETING SV | 37.50 | $338,635 | $0 | $33,749 | Yes (X) | |||||
| ANGELA COCHRAN | ||||||||||
| VP, PUBLISHING | 37.50 | $336,979 | $0 | $40,401 | Yes (X) | |||||
| BARTON LAWYER | ||||||||||
| VICE PRESIDENT - IT | 37.50 | $303,038 | $0 | $47,169 | Yes (X) | |||||
| STEPHEN GRUBBS MD | ||||||||||
| VP, CARE DELIVERY | 37.50 | $445,051 | $0 | $42,606 | Yes (X) | |||||
| KRISTEN NEESE | ||||||||||
| CHIEF MARKETING & COMMUNICATIONS OFFICER | 37.50 | $363,368 | $0 | $44,731 | Yes (X) | |||||
| PAULA KING | ||||||||||
| CHIEF HUMAN RESOURCES OFFICER | 37.50 | $362,762 | $0 | $44,731 | Yes (X) | |||||
| DEBORAH KAMIN PHD | ||||||||||
| VP, POLICY/ADVOCACY | 30.00 | 7.50 | $356,959 | $0 | $42,677 | Yes (X) | ||||
| MELISSA TAI | ||||||||||
| VP, CEIL & GENERAL COUNSEL | 29.50 | 8.00 | $350,115 | $0 | $49,281 | Yes (X) | ||||
| SEAN KHOZIN MD | ||||||||||
| FORMER CLQ CEO | 37.50 | $395,769 | $0 | $0 | Yes (X) | |||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $8,074,160 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $669,132 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 237 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | Yes (1) | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| FREEMAN | |||||
| PO BOX 734596 | DALLAS | TX | 753734596 | EVENT MANAGEMENT | $9,904,419 |
| THOUGHTWORKS INC | |||||
| 3799 PAYSPHERE CIRCLE | CHICAGO | IL | 60674 | IT CONSULTING | $7,093,917 |
| SPARGO INC | |||||
| 11208 WAPLES MILL ROAD 112 | FAIRFAX | VA | 22030 | EVENT MANAGEMENT | $4,797,390 |
| SMG FOOD & BEVERAGE LLC | |||||
| 747 HOWARD ST | SAN FRANCISCO | CA | 94103 | CATERING | $4,376,569 |
| AMAZON WEB SERVICES | |||||
| PO BOX 84023 | SEATTLE | WA | 981248423 | IT SERVICES | $3,573,335 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 92 | CntrctRcvdGreaterThan100KCnt |
| Related Organizations | $7,804,140 | RelatedOrganizationsAmt |
| Government Grants | $8,365,143 | GovernmentGrantsAmt |
| All Other Contributions | $90,000 | AllOtherContributionsAmt |
| Total Contributions | $16,259,283 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp (5 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt | Unrelated Business RevenueUnrelatedBusinessRevenueAmt |
|---|---|---|---|---|
| EDUCATIONAL MTGS & FEE | 900099 | $98,287,118 | $90,465,620 | $7,821,498 |
| SCIENTIFIC PUBLICATION | 513120 | $16,950,485 | $11,119,034 | $5,831,451 |
| RESEARCH | 900099 | $6,130,989 | $6,130,989 | |
| QUALITY OF CARE | 900099 | $5,871,793 | $5,871,793 | |
| OTHER | 900099 | $745,857 | $703,508 | $42,349 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $127,986,242 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $5,782,594 | TotalRevenueColumnAmt |
| Exclusion | $5,782,594 | ExclusionAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $5,450,417 | TotalRevenueColumnAmt |
| Exclusion | $5,450,417 | ExclusionAmt |
Gross Rents GrossRentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $979,838 | RealAmt |
Less Rental Expenses LessRentalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $0 | RealAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $979,838 | RealAmt |
Net Rental Income Or Loss NetRentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $979,838 | TotalRevenueColumnAmt |
| Exclusion | $979,838 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $21,297,347 | SecuritiesAmt |
| Other | $25,000,000 | OtherAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $22,935,037 | SecuritiesAmt |
| Other | $5,483,391 | OtherAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | -$1,637,690 | SecuritiesAmt |
| Other | $19,516,609 | OtherAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $17,878,919 | TotalRevenueColumnAmt |
| Exclusion | $17,878,919 | ExclusionAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $174,337,293 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $114,290,944 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $13,695,298 | UnrelatedBusinessRevenueAmt |
| Exclusion | $30,091,768 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part IX | Yes (X) | InfoInScheduleOPartIXInd |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,616,736 | TotalAmt |
| Program Services | $4,616,736 | ProgramServicesAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $15,760 | TotalAmt |
| Program Services | $15,760 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $6,641,015 | TotalAmt |
| Program Services | $5,199,633 | ProgramServicesAmt |
| Management And General | $1,441,382 | ManagementAndGeneralAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $49,159,160 | TotalAmt |
| Program Services | $38,489,539 | ProgramServicesAmt |
| Management And General | $10,669,621 | ManagementAndGeneralAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,672,281 | TotalAmt |
| Program Services | $2,875,240 | ProgramServicesAmt |
| Management And General | $797,041 | ManagementAndGeneralAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $6,598,315 | TotalAmt |
| Program Services | $5,166,201 | ProgramServicesAmt |
| Management And General | $1,432,114 | ManagementAndGeneralAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,207,845 | TotalAmt |
| Program Services | $3,294,564 | ProgramServicesAmt |
| Management And General | $913,281 | ManagementAndGeneralAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $721,399 | TotalAmt |
| Program Services | $681,188 | ProgramServicesAmt |
| Management And General | $40,211 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $136,900 | TotalAmt |
| Program Services | $2,500 | ProgramServicesAmt |
| Management And General | $134,400 | ManagementAndGeneralAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $104,026 | TotalAmt |
| Management And General | $104,026 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $24,842,957 | TotalAmt |
| Program Services | $18,916,090 | ProgramServicesAmt |
| Management And General | $5,926,867 | ManagementAndGeneralAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $705,816 | TotalAmt |
| Program Services | $693,882 | ProgramServicesAmt |
| Management And General | $11,934 | ManagementAndGeneralAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $5,420,746 | TotalAmt |
| Program Services | $3,834,822 | ProgramServicesAmt |
| Management And General | $1,585,924 | ManagementAndGeneralAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $9,692,065 | TotalAmt |
| Program Services | $6,893,709 | ProgramServicesAmt |
| Management And General | $2,798,356 | ManagementAndGeneralAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,198,932 | TotalAmt |
| Program Services | $1,925,134 | ProgramServicesAmt |
| Management And General | $1,273,798 | ManagementAndGeneralAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $5,802,064 | TotalAmt |
| Program Services | $4,824,036 | ProgramServicesAmt |
| Management And General | $978,028 | ManagementAndGeneralAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $20,612,159 | TotalAmt |
| Program Services | $20,607,946 | ProgramServicesAmt |
| Management And General | $4,213 | ManagementAndGeneralAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,073,425 | TotalAmt |
| Program Services | $614,692 | ProgramServicesAmt |
| Management And General | $458,733 | ManagementAndGeneralAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,852,923 | TotalAmt |
| Program Services | $2,206,359 | ProgramServicesAmt |
| Management And General | $1,646,564 | ManagementAndGeneralAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $861,769 | TotalAmt |
| Program Services | $624,700 | ProgramServicesAmt |
| Management And General | $237,069 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt |
|---|---|---|---|
| UBI TAX- FEDERAL AND ST | $1,896,781 | $1,896,781 | |
| CLINICAL SITE PAYMENTS | $1,336,000 | $1,336,000 | |
| BAD DEBT | $315,147 | $315,147 | |
| OTHER | $3,822 | $3,822 |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $155,488,043 | TotalAmt |
| Program Services | $124,719,334 | ProgramServicesAmt |
| Management And General | $30,768,709 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $15,476,157 | BOYAmt |
| EOY | $9,395,785 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $11,423,325 | BOYAmt |
| EOY | $12,675,262 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,887,690 | BOYAmt |
| EOY | $8,339,401 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $90,209,121 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $37,019,482 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $47,258,609 | BOYAmt |
| EOY | $53,189,639 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $166,910,803 | BOYAmt |
| EOY | $208,311,312 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,495,441 | BOYAmt |
| EOY | $4,627,040 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $251,452,025 | BOYAmt |
| EOY | $296,538,439 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $9,387,248 | BOYAmt |
| EOY | $11,247,077 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $46,146,231 | BOYAmt |
| EOY | $52,717,228 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $46,440,487 | BOYAmt |
| EOY | $43,521,229 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,143,153 | BOYAmt |
| EOY | $5,206,417 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $107,117,119 | BOYAmt |
| EOY | $112,691,951 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $143,605,840 | BOYAmt |
| EOY | $183,557,748 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $729,066 | BOYAmt |
| EOY | $288,740 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $144,334,906 | BOYAmt |
| EOY | $183,846,488 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $251,452,025 | BOYAmt |
| EOY | $296,538,439 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | $18,849,250 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $20,662,332 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | $0 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consolidated Basis Fincl Stmt | Yes (X) | ConsolidatedBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (1) | AuditCommitteeInd |
| Federal Grant Audit Required | Yes (1) | FederalGrantAuditRequiredInd |
| Federal Grant Audit Performed | Yes (1) | FederalGrantAuditPerformedInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Publicly Supported Org509a2 | Yes (X) | PubliclySupportedOrg509a2Ind |
Gifts Grants Contris Rcvd509 GiftsGrantsContrisRcvd509Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $7,525,300 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $6,446,971 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $7,826,511 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $9,250,760 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $16,259,283 | CurrentTaxYearAmt |
| Total | $47,308,825 | TotalAmt |
Gross Receipts Admissions GrossReceiptsAdmissionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $123,116,955 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $98,737,324 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $80,888,354 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $108,839,499 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $114,290,944 | CurrentTaxYearAmt |
| Total | $525,873,076 | TotalAmt |
Total509 Total509Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $130,642,255 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $105,184,295 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $88,714,865 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $118,090,259 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $130,550,227 | CurrentTaxYearAmt |
| Total | $573,181,901 | TotalAmt |
Amounts Rcvd Dsqlfy Person AmountsRcvdDsqlfyPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus2 Years | $75,000 | CurrentTaxYearMinus2YearsAmt |
| Total | $75,000 | TotalAmt |
Substantial Contributors Amt SubstantialContributorsAmtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Subst And Dsqlfy Prsns Tot SubstAndDsqlfyPrsnsTotGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus2 Years | $75,000 | CurrentTaxYearMinus2YearsAmt |
| Total | $75,000 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Support Total509 | $573,106,901 | PublicSupportTotal509Amt |
Gross Investment Income509 GrossInvestmentIncome509Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $8,610,595 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $18,248,056 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $15,214,892 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $15,080,053 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $12,212,849 | CurrentTaxYearAmt |
| Total | $69,366,445 | TotalAmt |
Investment Income And UBTI InvestmentIncomeAndUBTIGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $8,610,595 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $18,248,056 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $15,214,892 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $15,080,053 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $12,212,849 | CurrentTaxYearAmt |
| Total | $69,366,445 | TotalAmt |
Net Income From Other UBI NetIncomeFromOtherUBIGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $7,776,132 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $8,302,393 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $7,677,032 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $8,115,539 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $6,952,857 | CurrentTaxYearAmt |
| Total | $38,823,953 | TotalAmt |
Other Income509 OtherIncome509Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $251,085 | CurrentTaxYearMinus4YearsAmt |
| Total | $251,085 | TotalAmt |
Total Support Calendar Year TotalSupportCalendarYearGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $147,280,067 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $131,734,744 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $111,606,789 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $141,285,851 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $149,715,933 | CurrentTaxYearAmt |
| Total | $681,623,384 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Support CY509 | 0.84080 | PublicSupportCY509Pct |
| Public Support PY509 | 0.85180 | PublicSupportPY509Pct |
| Investment Income CY | 0.10180 | InvestmentIncomeCYPct |
| Investment Income PY | 0.09410 | InvestmentIncomePYPct |
| Thirty Thr Pct Suprt Tests CY509 | Yes (X) | ThirtyThrPctSuprtTestsCY509Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
Other Exempt Purpose Expend OtherExemptPurposeExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $155,488,043 | FilingOrganizationsTotalAmt |
Total Exempt Purpose Expend TotalExemptPurposeExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $155,488,043 | FilingOrganizationsTotalAmt |
Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $1,000,000 | FilingOrganizationsTotalAmt |
Grassroots Nontaxable GrassrootsNontaxableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $250,000 | FilingOrganizationsTotalAmt |
Tot Lbbyng Grassroot Mns Non Tx TotLbbyngGrassrootMnsNonTxGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $0 | FilingOrganizationsTotalAmt |
Tot Lbby Expend Mns Lbbyng Non Tx TotLbbyExpendMnsLbbyngNonTxGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $0 | FilingOrganizationsTotalAmt |
Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $1,000,000 | CurrentYearMinus3Amt |
| Current Year Minus2 | $1,000,000 | CurrentYearMinus2Amt |
| Current Year Minus1 | $1,000,000 | CurrentYearMinus1Amt |
| Current Year | $1,000,000 | CurrentYearAmt |
| Total | $4,000,000 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Lobbying Ceiling | $6,000,000 | LobbyingCeilingAmt |
Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $250,000 | CurrentYearMinus3Amt |
| Current Year Minus2 | $250,000 | CurrentYearMinus2Amt |
| Current Year Minus1 | $250,000 | CurrentYearMinus1Amt |
| Current Year | $250,000 | CurrentYearAmt |
| Total | $1,000,000 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grassroots Ceiling | $1,500,000 | GrassrootsCeilingAmt |
Schedule D IRS990ScheduleD
Buildings BuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $54,234,015 | OtherCostOrOtherBasisAmt |
| Depreciation | $18,104,403 | DepreciationAmt |
| Book Value | $36,129,612 | BookValueAmt |
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $763,557 | OtherCostOrOtherBasisAmt |
| Depreciation | $760,108 | DepreciationAmt |
| Book Value | $3,449 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $13,153,695 | OtherCostOrOtherBasisAmt |
| Depreciation | $8,284,385 | DepreciationAmt |
| Book Value | $4,869,310 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $22,057,854 | OtherCostOrOtherBasisAmt |
| Depreciation | $9,870,586 | DepreciationAmt |
| Book Value | $12,187,268 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $53,189,639 | TotalBookValueLandBuildingsAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)
| DescDesc | AmtAmt |
|---|---|
| DEFERRED COMPENSATION LIABILITY | $3,205,311 |
| OPERATING LEASE OBLIGATION | $2,001,106 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $5,206,417 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART X, LINE 2: | FormAndLineReferenceDesc |
| Explanation | THE ORGANIZATION ACCOUNTS FOR UNCERTAINTY IN INCOME TAXES IN ACCORDANCE WITH THE INCOME TAX TOPIC OF THE FINANCIAL ACCOUNTING STANDARDS BOARD ACCOUNTING STANDARDS CODIFICATION ("FASB ASC"). THE ORGANIZATION BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN AND, AS SUCH, DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE CONSOLIDATED FINANCIAL STATEMENTS. GENERALLY, THE ORGANIZATION IS NO LONGER SUBJECT TO INCOME TAX EXAMINATIONS BY THE U.S. FEDERAL, STATE OR LOCAL TAX AUTHORITIES FOR YEARS BEFORE 2020. | ExplanationTxt |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (8 entries)
| RegionRegionTxt | OfficesOfficesCnt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|---|
| NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES | 0 | 5 | PROGRAM SERVICES | QUALITY OF CARE | $1,062,285 |
| EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, | 0 | 0 | PROGRAM SERVICES | OUTREACH & EDUCATION | $75,268 |
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | 0 | 0 | PROGRAM SERVICES | OUTREACH & EDUCATION | $78,366 |
| SOUTH ASIA - AFGHANISTAN, BANGLADESH, BHUTAN, INDIA, MALDIVES, NEPAL, | 0 | 0 | PROGRAM SERVICES | OUTREACH & EDUCATION | $71,366 |
| SOUTH AMERICA - ARGENTINA, BOLIVIA, BRAZIL, CHILE, COLUMBIA, ECUADOR, | 0 | 0 | PROGRAM SERVICES | OUTREACH & EDUCATION | $17,690 |
| SUB-SAHARAN AFRICA - ANGOLA, BENIN, BOTSWANA, BURKINA FASO, | 0 | 0 | PROGRAM SERVICES | OUTREACH & EDUCATION | $44,233 |
| RUSSIA AND NEIGHBORING STATES - ARMENIA, AZERBIJAN, BELARUS, | 0 | 0 | PROGRAM SERVICES | OUTREACH & EDUCATION | $41,378 |
| MIDDLE EAST AND NORTH AFRICA - ALGERIA, BAHRAIN, DJIBOUTI, EGYPT, | 0 | 0 | PROGRAM SERVICES | OUTREACH & EDUCATION | $3,132 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 0 | SubtotalOfficesCnt |
| Subtotal Employees | 5 | SubtotalEmployeesCnt |
| Continuation Total Office | 0 | ContinuationTotalOfficeCnt |
| Continuation Total Employee | 0 | ContinuationTotalEmployeeCnt |
| Total Office | 0 | TotalOfficeCnt |
| Total Employee | 5 | TotalEmployeeCnt |
| Subtotal Spent | $1,393,718 | SubtotalSpentAmt |
| Continuation Spent | $0 | ContinuationSpentAmt |
| Total Spent | $1,393,718 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Region | EUROPE (INCLUDING ICELAND & GREENLAND) | RegionTxt |
| Purpose Of Grant | WORLD CANCER LEADER'S SUMMIT | PurposeOfGrantTxt |
| Cash Grant | $15,760 | CashGrantAmt |
| Non Cash Assistance | $0 | NonCashAssistanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 1 | Total501c3OrgCnt |
| Transfer To Foreign Corp | 0 | TransferToForeignCorpInd |
| Interest In Foreign Trust | 0 | InterestInForeignTrustInd |
| Foreign Corp Ownership | 0 | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | 0 | PassiveForeignInvestmestCoInd |
| Foreign Partnership | 0 | ForeignPartnershipInd |
| Boycott Countries | Yes (1) | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 2: | ASCO PROVIDED HONORARIA AND EXPENSE REIMBURSEMENTS TO MEETING SPEAKERS AND PRESENTERS. HONORARIA AND EXPENSE REIMBURSEMENTS WERE PAID DIRECTLY TO THE PRESENTERS. |
| PART I, LINE 3: | THE ACCRUAL METHOD WAS USED TO ACCOUNT FOR EXPENDITURES IN RELATION TO FOREIGN PROGRAM SERVICES. |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (17 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Non Cash AssistanceNonCashAssistanceAmt | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|---|
| NATIONAL ACADEMY OF SCIENCES | ||||||||
| 500 FIFTH STREET NW 8TH FLOOR | WASHINGTON | DC | 20001 | 530196932 | 501(C)(3) | $20,000 | $0 | SPONSORSHIP - ROUNDTABLE ON GENOMICS AND PRECISION HEALTH |
| NATIONAL COALITION FOR CANCER SURVIVORSHIP | ||||||||
| 8455 COLESVILLE RD SUITE 930 | SILVER SPRINGS | MD | 20910 | 850357897 | 501(C)(3) | $10,000 | $0 | CONTRIBUTION |
| HEALTH VOLUNTEERS OVERSEAS | ||||||||
| 1900 L STREET NW STE 310 | WASHINGTON | DC | 20036 | 521485477 | 501(C)(3) | $10,000 | $0 | VOLUNTEER ONCOLOGY SITES |
| UNIVERSITY OF CHICAGO | ||||||||
| 5801 ELLIS AVE | CHICAGO | IL | 60637 | 362177139 | 501(C)(3) | $74,167 | $0 | CONTRIBUTION |
| BOARD OF REGENTS OF THE UNIVERSITY OF THE UNIVERSITY OF MICHIGAN | ||||||||
| 3003 S STATE ST SUITE 8000 | ANN ARBOR | MI | 48109 | 386006309 | 501(C)(3) | $12,500 | $0 | CONTRIBUTION |
| YALE UNIVERSITY | ||||||||
| PO BOX 208239 | NEW HAVEN | CT | 06520 | 060646973 | 501(C)(3) | $130,000 | $0 | CONTRIBUTION |
| BRIGHAM & WOMEN'S HOSPITAL INC | ||||||||
| 75 FRANCIS ST | BOSTON | MA | 02116 | 042312909 | 501(C)(3) | $25,000 | $0 | CONTRIBUTION |
| UNIVERSITY OF PENNSYLVANIA | ||||||||
| 3451 WALNUT ST RM 305 | PHILADELPHIA | PA | 19104 | 231352685 | 501(C)(3) | $109,167 | $0 | CANCER RESEARCH & EDUCATION |
| FOX CHASE CANCER CENTER | ||||||||
| 3509 N BROAD ST RM 936 | PHILADELPHIA | PA | 19140 | 231352156 | 501(C)(3) | $47,500 | $0 | CONTRIBUTION |
| CONQUER CANCER FOUNDATION OF ASCO | ||||||||
| 2318 MILL RD SUITE 800 | ALEXANDRIA | VA | 22314 | 311667995 | 501(C)(3) | $3,652,500 | $0 | CONTRIBUTION |
| UNIVERISTY OF CINCINNATI | ||||||||
| 51 GOODMAN DRIVE | CINCINNATI | OH | 45219 | 316000989 | GOVT ENTITY | $46,667 | $0 | CONTRIBUTION |
| MAYO CLINIC JACKSONVILLE | ||||||||
| PO BOX 860334 | MINNEAPOLIS | MN | 554860334 | 593337028 | 501(C)(3) | $82,400 | $0 | CONTRIBUTION |
| JOHN HOPKINS UNIVERSITY | ||||||||
| 3910 KESWICK ROAD SUITE N2100 | BALTIMORE | MD | 21211 | 520595110 | 501(C)(3) | $82,400 | $0 | CONTRIBUTION |
| UNIVERSITY OF PITTSBURG | ||||||||
| 116 ATWOOD ST SUITE 201 | PITTSBURGH | PA | 15213 | 250965591 | 501(C)(3) | $15,000 | $0 | CONTRIBUTION |
| UNIVERSITY OF FLORIDA | ||||||||
| PO BOX 14425 | GAINSEVILLE | FL | 32604 | 590974739 | 501(C)(3) | $82,400 | $0 | CONTRIBUTION |
| UNIVERSITY OF TEXAS | ||||||||
| 2200 SAN ANTONIO ST | AUSTIN | TX | 78705 | 270426799 | 501(C)(3) | $82,400 | $0 | CONTRIBUTION |
| MEMORIAL SLOAN KETTERING CANCER CENTER | ||||||||
| 1275 YORK AVE | NEW YORK | NY | 10065 | 131924236 | 501(C)(3) | $82,400 | $0 | CONTRIBUTION |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 17 | Total501c3OrgCnt |
| Total Other Org | 0 | TotalOtherOrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | ASCO PROVIDES ASSISTANCE TO ORGANIZATIONS THAT SERVE THE CANCER CARE COMMUNITY. THE MAJORITY OF THESE GRANTS ARE MADE TO OTHER 501(C)(3) ORGANIZATIONS. GRANTS MADE TO NON-501(C)(3) ORGANIZATIONS ARE MADE PURSUANT TO A WRITTEN AGREEMENT THAT REQUIRED THE GRANT FUNDS TO BE USED FOR SPECIFIC EDUCATIONAL AND CHARITABLE PROJECTS, THAT THE GRANTEE RETURN ANY PORTION OF THE GRANT FUNDS THAT WERE NOT USED FOR SUCH PROJECTS, AND THAT THE GRANTEE PROVIDE ANNUAL NARRATIVE AND FINANCIAL REPORTS TO ASCO REGARDING GRANTEE'S USE OF THE GRANT FUNDS. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | Yes (1) | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | 0 | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | 0 | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | 0 | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | 0 | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | Yes (1) | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (17 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CLIFFORD A HUDIS MD | ||||||||||||||
| CEO | $1,049,613 | $0 | $10,000 | $0 | $1,188 | $0 | $24,750 | $0 | $0 | $0 | $1,085,551 | $0 | $0 | $0 |
| DINA MICHELS ESQ | ||||||||||||||
| SECRETARY, EVP & COO | $644,561 | $0 | $40,000 | $0 | $1,188 | $0 | $24,750 | $0 | $18,042 | $0 | $728,541 | $0 | $0 | $0 |
| JULIE R GRALOW MD | ||||||||||||||
| EVP & CMO | $621,212 | $0 | $10,000 | $0 | $1,188 | $0 | $24,750 | $0 | $18,042 | $0 | $675,192 | $0 | $0 | $0 |
| CARMEN JACKSON | ||||||||||||||
| CEO - CLQ | $499,855 | $0 | $15,000 | $0 | $270 | $0 | $24,750 | $0 | $24,669 | $0 | $564,544 | $0 | $0 | $0 |
| NANCY DALY MS MPH | ||||||||||||||
| EVP & CONQUER CANCER CEO | $504,351 | $0 | $10,000 | $0 | $2,286 | $0 | $24,750 | $0 | $17,927 | $0 | $559,314 | $0 | $0 | $0 |
| CHRISTOPHER MERLAN | ||||||||||||||
| EVP & CHIEF DIGITAL OFFICE | $464,954 | $0 | $10,000 | $0 | $774 | $0 | $24,750 | $0 | $19,981 | $0 | $520,459 | $0 | $0 | $0 |
| LINDA JENSEN | ||||||||||||||
| EVP & CFO | $463,824 | $0 | $10,000 | $0 | $3,708 | $0 | $24,750 | $0 | $18,042 | $0 | $520,324 | $0 | $0 | $0 |
| JAMIE VON ROENN MD MED | ||||||||||||||
| VP, EDU., SCIENCE & PROF. | $443,804 | $0 | $10,000 | $0 | $3,708 | $0 | $24,750 | $0 | $9,084 | $0 | $491,346 | $0 | $0 | $0 |
| STEPHEN GRUBBS MD | ||||||||||||||
| VP, CARE DELIVERY | $431,343 | $0 | $10,000 | $0 | $3,708 | $0 | $24,750 | $0 | $17,856 | $0 | $487,657 | $0 | $0 | $0 |
| KRISTEN NEESE | ||||||||||||||
| CHIEF MARKETING & COMMUNICATIONS OFF | $360,954 | $0 | $2,000 | $0 | $414 | $0 | $24,750 | $0 | $19,981 | $0 | $408,099 | $0 | $0 | $0 |
| PAULA KING | ||||||||||||||
| CHIEF HUMAN RESOURCES OFFICER | $351,574 | $0 | $10,000 | $0 | $1,188 | $0 | $24,750 | $0 | $19,981 | $0 | $407,493 | $0 | $0 | $0 |
| DEBORAH KAMIN PHD | ||||||||||||||
| VP, POLICY/ADVOCACY | $343,251 | $0 | $10,000 | $0 | $3,708 | $0 | $24,750 | $0 | $17,927 | $0 | $399,636 | $0 | $0 | $0 |
| MELISSA TAI | ||||||||||||||
| VP, CEIL & GENERAL COUNSEL | $339,395 | $0 | $10,450 | $0 | $270 | $0 | $24,750 | $0 | $24,531 | $0 | $399,396 | $0 | $0 | $0 |
| SEAN KHOZIN MD | ||||||||||||||
| FORMER CLQ CEO | $395,769 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $395,769 | $0 | $0 | $0 |
| ANGELA COCHRAN | ||||||||||||||
| VP, PUBLISHING | $326,709 | $0 | $10,000 | $0 | $270 | $0 | $24,750 | $0 | $15,651 | $0 | $377,380 | $0 | $0 | $0 |
| AMANDA DAVIS-AITKEN | ||||||||||||||
| VICE PRESIDENT, MEETING SV | $328,455 | $0 | $10,000 | $0 | $180 | $0 | $24,750 | $0 | $8,999 | $0 | $372,384 | $0 | $0 | $0 |
| BARTON LAWYER | ||||||||||||||
| VICE PRESIDENT - IT | $292,624 | $0 | $10,000 | $0 | $414 | $0 | $22,500 | $0 | $24,669 | $0 | $350,207 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 4A | SEAN KHOZIN RECEIVED SEVERANCE IN THE AMOUNT OF $395,769 IN 2023. |
| PART I, LINE 7 | THE ORGANIZATION HAS A DISCRETIONARY BONUS PLAN UNDER WHICH SELECTED EMPLOYEES, INCLUDING OFFICERS, KEY EMPLOYEES, AND OTHER EMPLOYEES ARE COMPENSATED BASED ON PERFORMANCE AND THE ACHIEVEMENT OF ORGANIZATIONAL GOALS. BONUSES FOR KEY EMPLOYEES AND HIGHEST COMPENSATED EMPLOYEES ARE APPROVED BY THE CHIEF EXECUTIVE OFFICER WITH REVIEW AND APPROVAL BY THE COMPENSATION COMMITTEE OF THE BOARD, WHERE APPROPRIATE. BONUSES FOR THE CHIEF EXECUTIVE OFFICER, IF ANY, ARE REVIEWED BY THE COMPENSATION COMMITTEE AS PART OF THE CHIEF EXECUTIVE OFFICER'S ANNUAL COMPENSATION REVIEW PROCESS, AND APPROVED BY THE BOARD OF DIRECTORS. IN ADDITION, THE ORGANIZATION AWARDS MODEST AMOUNTS TO EMPLOYEES ON ACHIEVING CERTAIN NUMBER OF YEARS OF EMPLOYMENT. FROM TIME TO TIME, THE ORGANIZATION MAY MAKE STANDARD PAYMENTS TO ITS EMPLOYEES IN GOOD STANDING WITH MINIMUM TIME OF EMPLOYMENT TO RECOGNIZE EFFORT AND COMMITMENT TO THE ORGANIZATION'S GOALS IN THAT YEAR. |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (10 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART VI, SECTION A, LINE 1A | AS OF DECEMBER 31, 2023, THE BOARD OF DIRECTORS OF ASCO INCLUDED 18 MEMBERS WITH THE RIGHT TO VOTE ON ALL MATTERS THAT COME BEFORE THE BOARD OF DIRECTORS. THE BOARD OF DIRECTORS ALSO INCLUDED TWO EX-OFFICIO DIRECTORS WITHOUT THE RIGHT TO VOTE, WHO WERE THE CHIEF EXECUTIVE OFFICER OF ASCO (CEO) AND THE CHAIR OF THE BOARD OF DIRECTORS OF ASCO'S RELATED 501(C)(3) ORGANIZATION, THE CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY. DURING THE REPORTING YEAR, THE BOARD OF DIRECTORS DELEGATED AUTHORITY TO ACT ON ITS BEHALF TO THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS, CONSISTENT WITH ASCO'S BYLAWS. PURSUANT TO THE BYLAWS, THE VOTING MEMBERS OF THE EXECUTIVE COMMITTEE ARE THE PRESIDENT, THE PRESIDENT-ELECT, THE CHAIR, THE PAST PRESIDENT, THE TREASURER, THE TREASURER-ELECT, AND THOSE DIRECTORS SERVING THE FINAL YEAR OF THEIR PRESENT TERMS. THE CEO IS A NON-VOTING MEMBER OF THE EXECUTIVE COMMITTEE. ALL EXECUTIVE COMMITTEE MEMBERS ARE MEMBERS OF ASCO'S BOARD OF DIRECTORS. THE SCOPE OF THE EXECUTIVE COMMITTEE'S AUTHORITY IS ESTABLISHED BY ASCO'S BYLAWS, WHICH PROVIDE THAT, EXCEPT TO THE EXTENT SPECIFICALLY PROHIBITED BY RESOLUTION OF THE BOARD OF DIRECTORS OR OTHERWISE PROHIBITED BY LAW, THE EXECUTIVE COMMITTEE OF THE BOARD IS EMPOWERED TO MAKE AND IMPLEMENT MAJOR DECISIONS BETWEEN BOARD MEETINGS, AND IT MAY ACT ON ITEMS REQUIRING ACTION PRIOR TO THE NEXT ANNOUNCED MEETING OF THE BOARD OF DIRECTORS. ALL ACTIONS OF THE EXECUTIVE COMMITTEE ARE REPORTED TO THE BOARD OF DIRECTORS AT THE NEXT MEETING OF THE BOARD OF DIRECTORS IMMEDIATELY FOLLOWING THE ACTION TAKEN BY THE EXECUTIVE COMMITTEE, CONSISTENT WITH ASCO'S BYLAWS. |
| FORM 990, PART VI, SECTION A, LINE 6 | ALL ASCO MEMBERS MUST BE ONCOLOGY MEDICAL PROFESSIONALS, DEFINED AS INDIVIDUALS WHO MEET ANY OF THE FOLLOWING QUALIFICATIONS: (1) INDIVIDUALS WHOSE PROFESSIONAL CREDENTIALS AND ACTIVITIES INVOLVE CANCER PATIENT CARE AND/OR RESEARCH, EDUCATION, OR ADVOCACY IN THE BIOLOGY, DIAGNOSIS, PREVENTION OR TREATMENT OF HUMAN CANCER; (2) INDIVIDUALS WHO ARE RETIRED FROM PROFESSIONAL ACTIVITIES, BUT WHOSE PROFESSIONAL ACTIVITIES PRIOR TO RETIREMENT INCLUDED THOSE SET FORTH ABOVE; (3) INDIVIDUALS WHO ARE STUDENTS TRAINING TO BE PROFESSIONALS DESCRIBED ABOVE. VOTING MEMBERS ARE ONCOLOGY MEDICAL PROFESSIONALS WHO HAVE BEEN AWARDED AND HOLD THE DEGREE OF DOCTOR OF MEDICINE, DOCTOR OF OSTEOPATHY, DOCTOR OF PHILOSOPHY, DOCTOR OF PHARMACY, DOCTOR OF MEDICAL SCIENCE, DOCTOR OF NURSING SCIENCE, DOCTOR OF NURSING PRACTICE, OR EQUIVALENT DOCTORAL-LEVEL DEGREE AS DETERMINED FROM TIME TO TIME BY ASCO AND THE ASSOCIATION. ONLY VOTING MEMBERS ARE ELIGIBLE TO VOTE OR SERVE ON THE BOARD OF DIRECTORS, ON THE NOMINATING COMMITTEE, OR AS ELECTED OFFICERS. |
| FORM 990, PART VI, SECTION A, LINE 7A | VOTING MEMBERS OF ASCO ELECT ALL VOTING MEMBERS OF THE ASCO BOARD OF DIRECTORS. |
| FORM 990, PART VI, SECTION A, LINE 7B | ASCO'S CERTIFICATE OF INCORPORATION MAY ONLY BE AMENDED UPON THE VOTE OF THE MEMBERS ENTITLED TO VOTE, AND THE BYLAWS MAY ONLY BE AMENDED, AND DISSOLUTION OF THE CORPORATION MAY ONLY BE APPROVED WITH THE APPROVAL OF BOTH THE BOARD OF DIRECTORS AND VOTING MEMBERS OF ASCO. |
| FORM 990, PART VI, SECTION B, LINE 11B | AN ELECTRONIC COPY OF THE FINAL FORM WAS SENT, THROUGH A SECURE SITE, TO EACH MEMBER OF THE BOARD OF DIRECTORS, AND WAS REVIEWED BY THE VICE PRESIDENT & CHIEF FINANCIAL OFFICER; THE CHIEF EXECUTIVE OFFICER; AND THE EXECUTIVE VICE PRESIDENT & CHIEF OPERATING OFFICER & CHIEF LEGAL OFFICER PRIOR TO FILING. |
| FORM 990, PART VI, SECTION B, LINE 12C | ASCO MAINTAINS A NUMBER OF WRITTEN CONFLICTS OF INTEREST POLICIES AND STANDARDS REGARDING THE DISCLOSURE AND MANAGEMENT OF CONFLICTS OF INTEREST. THESE POLICIES AND STANDARDS COVER ALL ASCO MEMBERS AND EMPLOYEES, DIRECTORS, OFFICERS, COMMITTEE MEMBERS, AND CERTAIN FAMILY MEMBERS (E.G. SPOUSE, DEPENDENT CHILDREN). COVERED INDIVIDUALS ARE ASKED TO DISCLOSE FINANCIAL INTERESTS IN OR OTHER RELATIONSHIPS WITH ENTITIES THAT HAVE RELEVANT COMMERCIAL INTERESTS, INCLUDING EMPLOYMENT OR LEADERSHIP POSITIONS, CONSULTANT OR ADVISORY ROLES, STOCK OWNERSHIP, HONORARIA, RESEARCH FUNDING, AND SERVICE AS AN EXPERT WITNESS. OFFICERS, DIRECTORS AND KEY EMPLOYEES ARE ALSO REQUIRED TO DISCLOSE SERVICE AS AN OFFICER, DIRECTOR, OR TRUSTEE OF ANY OTHER PROFESSIONAL OR ADVOCACY ORGANIZATION RELATING TO SCIENCE OR HEALTH CARE. COMPLETION OF A DISCLOSURE FORM IS REQUIRED AT THE INITIATION OF SERVICE AND UPDATED ANNUALLY THEREAFTER AND WHEN ANY MATERIAL CHANGES OCCUR. ASCO'S CONFLICT OF INTEREST POLICIES ARE INTENDED TO HELP GUIDE THE MANAGEMENT OF ACTUAL, POTENTIAL, AND PERCEIVED CONFLICTS OF INTEREST THROUGH DISCLOSURE OF FINANCIAL INTERESTS OR OTHER RELATIONSHIPS. WHERE THE NATURE AND EXTENT OF A FINANCIAL RELATIONSHIP SUGGEST DISCLOSURE IS NOT ADEQUATE TO MANAGE A REAL OR POTENTIAL CONFLICT, COVERED INDIVIDUALS ARE REQUIRED TO RECUSE THEMSELVES FROM DECISION-MAKING. RECUSAL MAY BE SELF-SELECTED, OR MAY BE REQUESTED BY THE COMMITTEE CHAIR, OFFICER, OR EXECUTIVE-LEVEL STAFF MEMBERS. IN ADDITION, IF ASCO WERE TO CONTEMPLATE ENTERING INTO A TRANSACTION OR ARRANGEMENT THAT MIGHT BENEFIT THE PRIVATE INTEREST OF ANY INTERESTED PERSON (I.E. AN ASCO DIRECTOR, PRINCIPAL OFFICER, OR MEMBER OF AN ASCO COMMITTEE WITH BOARD DELEGATED POWERS WHO HAS A DIRECT OR INDIRECT FINANCIAL INTEREST IN THE TRANSACTION), IT MUST FOLLOW A SPECIFIC PROCEDURE TO MANAGE THE CONFLICT, INCLUDING CONSIDERING ALTERNATIVE TRANSACTIONS THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. |
| FORM 990, PART VI, SECTION B, LINE 15 | COMPENSATION OF CHIEF EXECUTIVE OFFICER (CEO): THE DUTIES OF THE CEO OF ASCO INCLUDE SERVING AS: THE CEO OF ASCO, THE EXECUTIVE VICE CHAIR OF ASCO'S NON-PROFIT, 501(C)(3) TAX- EXEMPT RELATED ORGANIZATION, CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (CC); THE CEO OF ASCO'S NON-PROFIT, 501(C)(6) TAX-EXEMPT RELATED ORGANIZATION, ASCO ASSOCIATION (D/B/A ASSOCIATION FOR CLINICAL ONCOLOGY)(ASSOCIATION), THE PRESIDENT OF QOPI CERTIFICATION PROGRAM, LLC; THE PRESIDENT OF ASCO LEASING LLC, AND THE CHAIR OF THE BOARD OF GOVERNORS OF CANCERLINQ LLC. ALL ORGANIZATIONS LISTED ARE RELATED ORGANIZATIONS OF ASCO. THE WRITTEN EMPLOYMENT CONTRACT BETWEEN THE CEO AND ASCO ADDRESSES COMPENSATION OF THE CEO. THE COMPENSATION OF THE CEO WAS DETERMINED BY THE ASCO BOARD OF DIRECTORS, FOLLOWING THE REVIEW AND RECOMMENDATION OF THE BOARD COMPENSATION COMMITTEE. THE COMPENSATION COMMITTEE CONSULTED WITH INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE COMPENSATION FOR THE CEO WAS REASONABLE. THE REVIEW, RECOMMENDATION, AND DETERMINATION OF THE CEO'S COMPENSATION BASED ON THE ABOVE-DESCRIBED PROCESS WAS MOST RECENTLY UNDERTAKEN IN 2023. THE COMPENSATION OF THE FOLLOWING POSITIONS WAS CONSIDERED AND APPROVED BY THE ASCO BOARD COMPENSATION COMMITTEE, AFTER RECEIVING THE RECOMMENDATION OF THE CEO AND AN INDEPENDENT COMPENSATION CONSULTANT. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE COMPENSATION FOR EACH OF THE POSITIONS WAS REASONABLE. - EXECUTIVE VICE PRESIDENT & CHIEF OPERATING OFFICER & CHIEF LEGAL OFFICER & ASCO SECRETARY (EVP & COO): THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE EVP & COO BASED ON THE ABOVE DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2023. THE EVP & COO'S COMPENSATION WAS ALSO REVIEWED AND APPROVED BY THE BOARD OF DIRECTORS, AS REQUIRED UNDER STATE LAW. - EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER (EVP & CFO): THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE EVP & CFO BASED ON THE ABOVE-DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2023. - EXECUTIVE VICE PRESIDENT & CHIEF MEDICAL OFFICER (EVP & CMO): THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE EVP & CMO BASED ON THE ABOVE-DESCRIBED PROCESS WAS MOST RECENTLY UNDERTAKEN IN 2023. - EXECUTIVE VICE PRESIDENT & CHIEF DIGITAL OFFICER (EVP & CDO): THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE EVP & CDO BASED ON THE ABOVE-DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2023. - EXECUTIVE VICE PRESIDENT OF ASCO & CHIEF EXECUTIVE OFFICER OF THE CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (EVP & CC CEO): THE EVP & CC CEO IS AN EMPLOYEE OF ASCO. THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE EVP & CC CEO BASED ON THE ABOVE-DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2023. - EXECUTIVE VICE PRESIDENT OF ASCO & CHIEF EXECUTIVE OFFICER OF CANCERLINQ LLC (EVP & CLQ CEO): THE EVP & CLQ CEO IS AN EMPLOYEE OF ASCO. THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE EVP & CC CEO BASED ON THE ABOVE-DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2023. |
| FORM 990, PART VI, SECTION C, LINE 18 | ASCO'S FORM 1023, 990 AND 990-T ARE MADE AVAILABLE TO THE PUBLIC FROM ASCO UPON REQUEST. |
| FORM 990, PART VI, SECTION C, LINE 19 | ASCO'S GOVERNING DOCUMENTS ARE AVAILABLE TO THE PUBLIC FROM ASCO UPON REQUEST. ASCO'S CERTIFICATE OF INCORPORATION IS ALSO AVAILABLE TO THE PUBLIC THROUGH THE SECRETARY OF STATE OF NEW YORK. ASCO'S CONFLICT OF INTEREST POLICY IS POSTED ON ASCO'S WEBSITE AND IS AVAILABLE TO THE PUBLIC FROM ASCO UPON REQUEST. |
| FORM 990, PART IX, LINE 11G | OTHER PROFESSIONAL SERVICES: PROGRAM SERVICE EXPENSES 18,916,090. MANAGEMENT AND GENERAL EXPENSES 5,926,867. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 24,842,957. |
Schedule R IRS990ScheduleR
Id Disregarded Entities IdDisregardedEntitiesGrp (2 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile StateLegalDomicileStateCd | Total IncomeTotalIncomeAmt | End Of Year AssetsEndOfYearAssetsAmt | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt |
|---|---|---|---|---|---|---|---|---|---|
| ASCO LEASING LLC | |||||||||
| 2318 MILL RD SUITE 800 | ALEXANDRIA | VA | 22314 | 273378225 | RENTAL | VA | $0 | $0 | ASCO |
| CANCERLINQ LLC | |||||||||
| 2318 MILL RD SUITE 800 | ALEXANDRIA | VA | 22314 | 472315885 | QUALITY IMPV | VA | $7,558,629 | $0 | ASCO |
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (3 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile StateLegalDomicileStateCd | Exempt Code SectionExemptCodeSectionTxt | Public Charity StatusPublicCharityStatusTxt | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt | Controlled OrganizationControlledOrganizationInd |
|---|---|---|---|---|---|---|---|---|---|---|
| CONQUER CANCER FOUNDATION OF ASCO | ||||||||||
| 2318 MILL RD SUITE 800 | ALEXANDRIA | VA | 22314 | 311667995 | GRANTMAKING | VA | 501(C)(3) | LINE 7 | ASCO | Yes (1) |
| ASCO ASSOCIATION | ||||||||||
| 2318 MILL RD SUITE 800 | ALEXANDRIA | VA | 22314 | 833561693 | MEMBER SERVS | VA | 501(C)(6) | ASCO | Yes (1) | |
| ASCO ASSOCIATION POLITICAL ACTION COMM | ||||||||||
| 2318 MILL RD SUITE 800 | ALEXANDRIA | VA | 22314 | 844213157 | ADVOCACY | VA | 527 | ASCO ASSOC | 0 | |
Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp
Related Organization Name RelatedOrganizationName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | CANCERLINQ LABS LLC | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2318 MILL ROAD SUITE 800 | AddressLine1Txt |
| City | ALEXANDRIA | CityNm |
| State Abbreviation | VA | StateAbbreviationCd |
| ZIP | 22314 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 881804716 | EIN |
| Primary Activities | DATABASE TECHNOLOGY | PrimaryActivitiesTxt |
| Legal Domicile State | VA | LegalDomicileStateCd |
| Direct Controlling NA | N/A | DirectControllingNACd |
| Entity Type | C | EntityTypeTxt |
| Controlled Organization | 0 | ControlledOrganizationInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | 0 | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | Yes (1) | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | Yes (1) | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | 0 | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | 0 | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | 0 | DivRelatedOrganizationInd |
| Asset Sale To Other Org | 0 | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | 0 | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | 0 | AssetExchangeInd |
| Rental Of Facilities To Oth Org | Yes (1) | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | 0 | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | Yes (1) | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | Yes (1) | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | Yes (1) | SharingOfFacilitiesInd |
| Paid Employees Sharing | Yes (1) | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | Yes (1) | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | Yes (1) | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | 0 | TransferToOtherOrgInd |
| Transfer From Other Org | 0 | TransferFromOtherOrgInd |
Transactions Related Org TransactionsRelatedOrgGrp (6 entries)
| Transaction TypeTransactionTypeTxt | InvolvedInvolvedAmt | Method Of Amount DeterminationMethodOfAmountDeterminationTxt |
|---|---|---|
| CONQUER CANCER FOUNDATION OF ASCO | ||
| B | $3,652,500 | FMV |
| CONQUER CANCER FOUNDATION OF ASCO | ||
| C | $7,804,140 | FMV |
| ASCO ASSOCIATION | ||
| N | $821,288 | FMV |
| CONQUER CANCER FOUNDATION OF ASCO | ||
| N | $158,550 | FMV |
| ASCO ASSOCIATION | ||
| Q | $856,123 | FMV |
| CONQUER CANCER FOUNDATION OF ASCO | ||
| Q | $8,910,923 | FMV |